HIV prevalence is increasing worldwide because people on antiretroviral therapy are living
longer, although new infections decreased from 3· 3 million in 2002, to 2· 3 million in 2012 …

Background Women may have persistent risk of HIV acquisition during pregnancy and
postpartum. Estimating risk of HIV during these periods is important to inform optimal …

Background Antiretroviral preexposure prophylaxis is a promising approach for preventing
human immunodeficiency virus type 1 (HIV-1) infection in heterosexual populations …

Importance An estimated 1.1 million individuals in the United States are currently living with
HIV, and more than 700 000 persons have died of AIDS since the first cases were reported …

Background Increased uptake of HIV testing by men in sub-Saharan Africa is essential for
the success of combination prevention. Self-testing is an emerging approach with high …

To summarize the literature regarding susceptibility of pregnant women to infectious
diseases and severity of resulting disease, we conducted a review using a PubMed search …

The effectiveness of HIV pre-exposure prophylaxis (PrEP) hinges on adherence, which has
been restricted by multifaceted barriers. Uptake of PrEP has been impeded by poor access …

Preexposure prophylaxis (PrEP), in which HIV-uninfected persons with ongoing HIV risk use
antiretroviral medications to reduce their risk of acquiring HIV infection, is an efficacious and …

Although pre-exposure prophylaxis (PrEP)—the use of antiretroviral drugs by non-infected
people to prevent the acquisition of HIV—is a promising preventive option, important public …

Human immunodeficiency virus (HIV) remains a global infectious diseases threat that
disproportionally affects women. Beyond social and political factors, biological and genetic …